Maquet Cardiovascular has secured US Federal Trade Commission approval to acquire Atrium Medical, a developer of medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery.

Atrium will now operate as an independent, self-contained business unit of Maquet, preserving its current brand name.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Maquet Cardiovascular president and CEO Christian Keller said that the commission’s approval will allow the company to use Atrium’s synergies and provide customers with an enhanced product offering.

"In addition to Atrium’s innovative product line, we look forward to leveraging future scientific and technological advances resulting from this acquisition, so that we may continue to deliver ground-breaking solutions to customers and patients worldwide," Keller added.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact